Cita APA (7a ed.)
Wang, J., Gao, Y., Ruan, Z., Yang, D., Li, H., Qiao, S., . . . Jiang, B. (2025). The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects. Journal of Clinical Pharmacology, 65(11), 1474-1485.
Cita Chicago Style (17a ed.)
Wang, Jia‐ying, et al. "The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects." Journal of Clinical Pharmacology 65, no. 11 (2025): 1474-1485.
Cita MLA (9a ed.)
Wang, Jia‐ying, et al. "The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects." Journal of Clinical Pharmacology, vol. 65, no. 11, 2025, pp. 1474-1485.
Precaución: Estas citas no son 100% exactas.